Dr. Lal PathLabs to discuss Q2 and H1 FY27 results on November 4

Board & Shareholder Meetings View source PDF Explain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹1890.00

prior close

₹1885.20

announcement price

After-mkt

timing

Nifty Smallcap 250marketpendingvs market: pending

Healthcare Service Provider peers, median of 27sector-0.1%+1.7% vs sector

On the reaction day the stock moved 1.7 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.1

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7pendingpending-0.1+1.7

Next day

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Lal PathLabs will hold an investor and analyst conference call at 6:00 PM IST on November 4, 2026, to discuss its Q2 and H1 FY27 financial and operating performance. Results will be announced the same day. The Executive Chairman, CEO, Group CFO and International Business CEO will represent the company and address participants' questions.

Likely market impact

No results or guidance are disclosed yet. The stock could react to the November 4 results and management commentary during the call.